Allergy Asthma Respir Dis.  2013 Dec;1(4):391-394. 10.4168/aard.2013.1.4.391.

Chronic pulmonary complications due to toxic epidermal necrolysis

Affiliations
  • 1Department of Pediatrics, Inha University School of Medicine, Incheon, Korea. kimjhmd@inha.ac.kr

Abstract

Toxic epidermal necrolysis (TEN) is the most severe form of skin reactions caused by drugs or infection. Acute pulmonary complications in TEN are often observed. The mortality is especially high in those who suffer chronic pulmonary complications of TEN such as bronchiolitis obliterance, which occur as a consequence of bronchial epithelial injury. We report a case of a 16-year-old male who had required mechanical ventilation due to acute respiratory distress syndrome caused by TEN at 8 years of age. Although the patient initially recovered from acute respiratory distress syndrome, he required mechanical ventilation again due to severe chronic pulmonary complications of bronchiolitis obliterance and bronchiectasis caused by respiratory epithelial detachment. Thereafter, chronic bronchitis and chronic sinusitis has persisted due to mucosal ciliary dysfunction and several episodes of spontaneous pneumothorax has occurred. However, despite these persisting and serious sequelae of TEN, the patient has survived for 8 years. We report a rare case of a patient with long-term chronic pulmonary complications who had previously suffered TEN 8 years ago.

Keyword

Toxic epidermal necrolysis; Recurrent spontaneous pneumothorax; Pulmonary complication

MeSH Terms

Adolescent
Bronchiectasis
Bronchiolitis
Bronchitis, Chronic
Epidermal Necrolysis, Toxic*
Humans
Male
Mortality
Pneumothorax
Respiration, Artificial
Respiratory Distress Syndrome, Adult
Sinusitis
Skin

Figure

  • Fig. 1 Plain chest X-ray showed right pneumothorax and left residual pneumothorax.

  • Fig. 2 (A) Pulmonary findings of a high resolution computed tomography scan showed marked right pneumothorax. (B) Bronchiectasis and bronchiolitis obliterance were observed in the both lung field.

  • Fig. 3 (A) Biopsied tissues from the right upper lobe showed emphysematous change and 5-cm diameter bullae (H&E, ×12.5). (B) Septum interstitial tissue showed edematous change and multifocal lymphocyte and plasma cell infiltration (H&E, ×100).


Reference

1. Finkelstein Y, Soon GS, Acuna P, George M, Pope E, Ito S, et al. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics. 2011; 128:723–728.
Article
2. Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med. 2011; 39:1521–1532.
Article
3. Kim HI, Kim SW, Park GY, Kwon EG, Kim HH, Jeong JY, et al. Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients. Korean J Intern Med. 2012; 27:203–210.
Article
4. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010; 5:39.
Article
5. Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med. 1997; 23:1237–1244.
Article
6. Woo T, Saito H, Yamakawa Y, Komatsu S, Onuma S, Okudela K, et al. Severe obliterative bronchitis associated with Stevens-Johnson syndrome. Intern Med. 2011; 50:2823–2827.
Article
7. Edwards C, Penny M, Newman J. Mycoplasma pneumonia, Stevens-Johnson syndrome, and chronic obliterative bronchitis. Thorax. 1983; 38:867–869.
Article
8. Kamata T, Sakamaki F, Fujita H, Urano T, Mori M, Yamaguchi K, et al. Toxic epidermal necrolysis with tracheobronchial and pulmonary complications. Intern Med. 1994; 33:252–255.
Article
9. Virant FS, Redding GJ, Novack AH. Multiple pulmonary complications in a patient with Stevens-Johnson syndrome. Clin Pediatr (Phila). 1984; 23:412–414.
Article
10. Reyes de la Rocha S, Leonard JC, Demetriou E. Potential permanent respiratory sequela of Stevens-Johnson syndrome in an adolescent. J Adolesc Health Care. 1985; 6:220–223.
Article
11. Kim MJ, Lee KY. Bronchiolitis obliterans in children with Stevens-Johnson syndrome: follow-up with high resolution CT. Pediatr Radiol. 1996; 26:22–25.
Article
12. McIvor RA, Zaidi J, Peters WJ, Hyland RH. Acute and chronic respiratory complications of toxic epidermal necrolysis. J Burn Care Rehabil. 1996; 17:237–240.
Article
13. Kumar S, Tefferi A. Spontaneous pneumomediastinum and subcutaneous emphysema complicating bronchiolitis obliterans after allogeneic bone marrow transplantation: case report and review of literature. Ann Hematol. 2001; 80:430–435.
Article
14. Kamada N, Kinoshita K, Togawa Y, Kobayashi T, Matsubara H, Kohno M, et al. Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro/SS-A and a review of the published work. J Dermatol. 2006; 33:616–622.
Article
15. Roujeau JC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol. 1990; 23(6 Pt 1):1039–1058.
Article
16. Namdar T, Stang FH, Siemers F, Stollwerck PL, Wild Tv, Mailänder P, et al. [Mechanical ventilation in toxic epidermal necrolysis]. Handchir Mikrochir Plast Chir. 2011; 43:125–128.
17. Correia O, Delgado L, Barbosa IL, Campilho F, Fleming-Torrinha J. Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis. J Am Acad Dermatol. 2002; 47:58–62.
Article
18. Chadwick C, Marven SM, Vora AJ. Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans. Bone Marrow Transplant. 2004; 33:451–453.
Article
19. Matsumoto K, Yamauchi T, Ichikawa M, Masuda Y, Ogawa K, Arai T, et al. Bronchiolitis obliterans in a patient with chronic graft-versus-host disease after bone marrow transplantation. Nihon Kyobu Shikkan Gakkai Zasshi. 1996; 34:345–349.
20. Date H, Sano Y, Aoe M, Goto K, Tedoriya T, Sano S, et al. Living-donor lobar lung transplantation for bronchiolitis obliterans after Stevens-Johnson syndrome. J Thorac Cardiovasc Surg. 2002; 123:389–391.
Article
Full Text Links
  • AARD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr